Crypto Hack Theft Falls in June to $76M as Attacks Ebb
June's crypto hack theft falls to $76 million across 40 incidents, led by a $31 million Humanity Protocol breach, acc...
Watch Out Budget Categories
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articlesTesla Margin Expansion vs Rivian’s R2 Bet: Two Paths
Tesla accelerates margin gains in Q1 2026 as Rivian pushes its R2 strategy through partnerships and new products, hig...
First Major Robotics Here: IPO Sparks 2H 2026 Bets for Investors
A landmark humanoid-robotics listing has hit the market, prompting a renewed focus on robotics stocks as traders pric...
Two Sector Income ETFs Outyield S&P 500 by Over 2%
Two sector income ETFs are delivering yields well above the S&P 500 as investors price in a possible recession. The g...
Prediction: SpaceX Stock Will Reach a 2026 Price Target
What could SpaceX stock be worth by the end of 2026? This thoughtful guide weighs base, bullish, and bearish cases, p...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Nasdaq Income Without Megacap: A Look at JEPQ's Tradeoffs
Investors chase steady monthly cash without loading up on megacap tech. This piece explains how a Nasdaq-focused inco...
Rivian Craters Share Offering Sparks EV Rally Reversal
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
Ripple’s $200M Rail Acquisition Faces AngelList Wind-Down
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...
Office Conversions Face Scrutiny After Pfizer HQ Incident
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
Chip Stocks Buy Weakness: Top Name Set for Big H2 Gains
A leading chipmaker signals strong second-half potential, even as the broader sector wrestles with volatility. Analys...
Is This Biotech Stock After Its Massive Rally a Smart Buy?
A biotech stock can surge on hype, but smart investors dig into the data behind the rally. This guide breaks down how...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status